Should Small Papillary Thyroid Cancer Be Observed? A Population-Based Study

由 Nilubol, Naris, Kebebew, Electron
發表在 Cancer (2014)

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

由 Boufraqech, Myriem, Nilubol, Naris
發表在 Cancers (Basel) (2019)

Current Status and Future Targeted Therapy in Adrenocortical Cancer

由 Alyateem, George, Nilubol, Naris
發表在 Front Endocrinol (Lausanne) (2021)

Emerging therapy for adrenocortical carcinoma

由 Aufforth, Rachel D, Nilubol, Naris
發表在 Int J Endocr Oncol (2014)

Multivariate Analysis of the Relationship Between Male Sex, Disease-Specific Survival, and Features of Tumor Aggressiveness in Thyroid Cancer of Follicular Cell Origin

由 Nilubol, Naris, Zhang, Lisa, Kebebew, Electron
出版 2013

New Therapies for Advanced Thyroid Cancer

由 Laha, Diprajan, Nilubol, Naris, Boufraqech, Myriem
發表在 Front Endocrinol (Lausanne) (2020)

Some Considerations in Treating Malignant Head and Neck Paragangliomas

由 Jha, Abhishek, Nilubol, Naris, Pacak, Karel
發表在 JAMA Otolaryngol Head Neck Surg (2020)

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure

由 Libutti, Steven K., Tamarkin, Lawrence, Nilubol, Naris
發表在 Oncotarget (2018)

Loss of CPSF2 Expression Is Associated with Increased Thyroid Cancer Cellular Invasion and Cancer Stem Cell Population, and More Aggressive Disease

由 Nilubol, Naris, Boufraqech, Myriem, Zhang, Lisa, Kebebew, Electron
出版 2014

PROGNOSTIC UTILITY OF 24-HOUR URINARY 5-HIAA DOUBLING TIME IN PATIENTS WITH NEUROENDOCRINE TUMORS

由 Tirosh, Amit, Nilubol, Naris, Patel, Dhaval, Kebebew, Electron
發表在 Endocr Pract (2018)

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment

由 Laha, Dipranjan, Grant, Robert, Mishra, Prachi, Nilubol, Naris
發表在 Front Immunol (2021)

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?

由 Babic, Bruna, De Roulet, Amory, Volpe, Anita, Nilubol, Naris
發表在 J Endocr Soc (2018)

Molecular Pathways Associated with Mortality in Papillary Thyroid Cancer

由 Nilubol, Naris, Sukchotrat, Chotiya, Zhang, Lisa, He, Mei, Kebebew, Electron
發表在 Surgery (2011)

A Lymph Node Ratio–Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors

由 Gaitanidis, Apostolos, Patel, Dhaval, Nilubol, Naris, Tirosh, Amit, Kebebew, Electron
發表在 J Clin Endocrinol Metab (2017)

SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer

由 Patel, Dhaval, King, Timothy, Kebebew, Electron, Nilubol, Naris, Boufraqech, Myriem
發表在 J Endocr Soc (2019)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma

由 Tirosh, Amit, Boufraqech, Myriem, Nilubol, Naris, Kebebew, Electron, Patel, Dhaval
發表在 J Endocr Soc (2019)

Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing

由 Zhang, Lisa, He, Mei, Zhang, Yaqin, Nilubol, Naris, Shen, Min, Kebebew, Electron
出版 2012

Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report

由 Nilubol, Naris, Freedman, Esther M., Quezado, Martha M., Patel, Dhaval, Kebebew, Electron
發表在 J Clin Endocrinol Metab (2016)

Adrenocortical carcinoma and pulmonary embolism from tumoral extension

由 Shekhar, Skand, Gubbi, Sriram, Papadakis, Georgios Z, Nilubol, Naris, Hannah-Shmouni, Fady
發表在 Endocrinol Diabetes Metab Case Rep (2019)

Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas

由 Patel, Dhaval, Mehta, Amit, Nilubol, Naris, Dieckmann, William, Pacak, Karel, Kebebew, Electron
發表在 Ann Surg (2016)